This is a table of type proper and their frequencies. Use it to search & browse the list to learn more about your study carrel.
| proper | frequency |
|---|---|
| SARS | 1117 |
| COVID-19 | 1001 |
| CoV-2 | 860 |
| China | 269 |
| Disease | 211 |
| Wuhan | 198 |
| Coronavirus | 194 |
| ACE2 | 176 |
| Table | 167 |
| Health | 164 |
| ICU | 157 |
| COPD | 141 |
| PD | 122 |
| January | 122 |
| VR | 111 |
| CoV | 103 |
| PCR | 102 |
| Parkinson | 94 |
| TBI | 92 |
| CI | 91 |
| C | 88 |
| Clinical | 86 |
| RNA | 80 |
| Figure | 80 |
| CVD | 77 |
| Clin | 75 |
| Med | 75 |
| Syndrome | 73 |
| MSC | 71 |
| ARDS | 70 |
| Novel | 69 |
| RPCP | 66 |
| A | 66 |
| J | 65 |
| Italy | 65 |
| RBD | 64 |
| T | 64 |
| RT | 63 |
| December | 63 |
| S1 | 61 |
| March | 61 |
| MERS | 60 |
| PIMS | 59 |
| IL-6 | 59 |
| sha | 58 |
| II | 57 |
| Care | 57 |
| CR | 57 |
| USA | 56 |
| Japan | 55 |
| IgG | 54 |
| European | 54 |
| Germany | 53 |
| STIM | 53 |
| Study | 53 |
| TS | 53 |
| April | 51 |
| TNF | 50 |
| World | 49 |
| RPL | 49 |
| US | 48 |
| Society | 48 |
| Analysis | 48 |
| IgM | 47 |
| Patients | 46 |
| L | 46 |
| Association | 46 |
| Hospital | 45 |
| CXR | 45 |
| CT | 44 |
| Respiratory | 43 |
| HI | 43 |
| Organization | 42 |
| Review | 41 |
| Supplementary | 40 |
| IQR | 40 |
| meta | 40 |
| Angiotensin | 39 |
| X | 38 |
| Human | 38 |
| Covid-19 | 37 |
| Inflammatory | 37 |
| SIRT1 | 37 |
| University | 37 |
| α | 36 |
| S | 36 |
| Prevention | 36 |
| Medical | 36 |
| DIC | 36 |
| Asthma | 36 |
| New | 35 |
| CAD | 35 |
| PA | 35 |
| United | 35 |
| Treatment | 35 |
| States | 34 |
| Management | 34 |
| LUS | 34 |
| FMT | 34 |
| Control | 34 |
| Chronic | 34 |
| Research | 33 |
| Spain | 33 |
| Pneumonia | 33 |
| Institute | 33 |
| East | 33 |
| CRP | 33 |
| CC | 32 |
| Creative | 32 |
| Attribution | 32 |
| Commons | 32 |
| UK | 32 |
| GmbH | 32 |
| System | 32 |
| sestamibi | 32 |
| OS | 32 |
| S2 | 31 |
| Multisystem | 31 |
| Middle | 31 |
| HT | 31 |
| Center | 31 |
| Israel | 30 |
| ELISA | 30 |
| Children | 30 |
| IgA | 29 |
| February | 29 |
| Cardiac | 29 |
| Model | 29 |
| ritonavir | 29 |
| National | 28 |
| Committee | 28 |
| Europe | 28 |
| GCS | 28 |
| International | 28 |
| Korea | 28 |
| RAAS | 28 |
| Rehabilitation | 28 |
| Risk | 28 |
| SCI | 28 |
| tSCS | 28 |
| Pulmonary | 27 |
| CDI | 27 |
| Inc. | 27 |
| KD | 27 |
| max | 27 |
| R | 27 |
| SCS | 27 |
| SC | 27 |
| South | 26 |
| Pandemic | 26 |
| Infection | 26 |
| HIMC | 26 |
| HF | 26 |
| Chi | 26 |
| ED | 25 |
| Associated | 25 |
| D | 25 |
| N | 25 |
| MIS | 25 |
| Spinal | 25 |
| York | 25 |
| IFN | 24 |
| < | 24 |
| American | 24 |
| Brain | 24 |
| Data | 24 |
| EMG | 24 |
| Group | 24 |
| Virus | 24 |
| IVIG | 24 |
| Mesenchymal | 24 |
| Microbiota | 24 |
| North | 24 |
| Spike | 24 |
| Transplant | 24 |
| MD | 23 |
| ECG | 23 |
| Factors | 23 |
| AIS | 23 |
| May | 23 |
| PR | 23 |
| Outcomes | 23 |
| ± | 22 |
| TM | 22 |
| Systematic | 22 |
| Meta | 22 |
| June | 22 |
| J. | 22 |
| ALI | 22 |
| Global | 21 |
| Cardiovascular | 21 |
| City | 21 |
| Department | 21 |
| PTSD | 21 |
| ISS | 21 |
| QT | 21 |
| Scale | 21 |
| Stem | 21 |
| Guidelines | 20 |
| ACEI | 20 |
| Characteristics | 20 |
| CoVs | 20 |
| Cord | 20 |
| Epidemiology | 20 |
| F | 20 |
| mTc]Sestamibi | 20 |
| H1N1 | 20 |
| Heart | 20 |
| Impact | 20 |
| Intensive | 20 |
| LIMC | 20 |
| ROS | 20 |
| BNP | 19 |
| M | 19 |
| COVID | 19 |
| DM | 19 |
| HIV | 19 |
| Index | 19 |
| mg | 19 |
| QTc | 19 |
| Wii | 19 |
| sera | 19 |
| SPSS | 19 |
| Use | 19 |
| HRV | 18 |
| AI | 18 |
| CFR | 18 |
| Case | 18 |
| E | 18 |
| ERCP | 18 |
| • | 18 |
| FDA | 18 |
| HCoV | 18 |
| Emergency | 18 |
| IL-10 | 18 |
| RSV | 18 |
| Report | 18 |
| Receptor | 18 |
| azithromycin | 18 |
| ROC | 18 |
| Lung | 18 |
| Ltd. | 18 |
| General | 18 |
| III | 17 |
| AUC | 17 |
| Assessment | 17 |
| CBT | 17 |
| EE | 17 |
| Ebola | 17 |
| GGO | 17 |
| GI | 17 |
| July | 17 |
| KCDC | 17 |
| Medicine | 17 |
| Patient | 17 |
| Statistical | 17 |
| Stress | 17 |
| ms | 17 |
| Ki67 | 17 |
| Kidney | 16 |
| Adults | 16 |
| CD8 | 16 |
| Centers | 16 |
| Foundation | 16 |
| Immune | 16 |
| PSS-10 | 16 |
| Rapamycin | 16 |
| TGF | 16 |
| mm | 16 |
| ≤ | 16 |
| ≥ | 16 |
| IL-17 | 15 |
| ARB | 15 |
| Airway | 15 |
| B | 15 |
| Board | 15 |
| Coronaviruses | 15 |
| Diseases | 15 |
| Evaluation | 15 |
| Fecal | 15 |
| HR | 15 |
| Injury | 15 |
| Kawasaki | 15 |
| LOS | 15 |
| R0 | 15 |
| SD | 15 |
| Survey | 15 |
| Therapy | 15 |
| Transplantation | 15 |
| hydroxychloroquine | 15 |
| β | 15 |
| Cell | 14 |
| Declaration | 14 |
| Cov-2 | 14 |
| Computing | 14 |
| Cells | 14 |
| Efficacy | 14 |
| Cardiology | 14 |
| CA | 14 |
| Burnout | 14 |
| BWS | 14 |
| FI | 14 |
| Endoscopy | 14 |
| Hubei | 14 |
| Helsinki | 14 |
| Robert | 14 |
| tocilizumab | 14 |
| teledentistry | 14 |
| mL | 14 |
| Transmission | 14 |
| SF-36 | 14 |
| Poland | 14 |
| PHP | 14 |
| MDS | 14 |
| Koch | 14 |
| DP | 13 |
| Akt | 13 |
| Centre | 13 |
| CKD | 13 |
| BMI | 13 |
| Australia | 13 |
| NL63 | 13 |
| ANOVA | 13 |
| AMI | 13 |
| AKI | 13 |
| ADR | 13 |
| Guidance | 13 |
| Development | 13 |
| WHO | 13 |
| Hamming | 13 |
| Molecular | 13 |
| Spearman | 13 |
| SpO | 13 |
| Skills | 13 |
| Hospitalized | 13 |
| RNFL | 13 |
| Meier | 13 |
| Kaplan | 13 |
| Italian | 13 |
| IMB | 13 |
| I | 13 |
| Fr | 12 |
| Fisher | 12 |
| Exercise | 12 |
| Exacerbations | 12 |
| Effectiveness | 12 |
| CIR | 12 |
| Day | 12 |
| ILC2 | 12 |
| C. | 12 |
| Behavioural | 12 |
| BFI-10 | 12 |
| Anti | 12 |
| Age | 12 |
| Activation | 12 |
| ARF | 12 |
| IBD | 12 |
| Glasgow | 12 |
| Mitochondrial | 12 |
| Systems | 12 |
| Public | 12 |
| ng | 12 |
| choledocholithiasis | 12 |
| Whitney | 12 |
| Type | 12 |
| Severe | 12 |
| REVIEW | 12 |
| Practice | 12 |
| OCT | 12 |
| Mann | 12 |
| MMP-9 | 12 |
| M. | 12 |
| LPS | 12 |
| ISNCSCI | 12 |
| English | 11 |
| Electric | 11 |
| England | 11 |
| PRISMA | 11 |
| Fit | 11 |
| IES | 11 |
| DOI | 11 |
| Distress | 11 |
| 8) | 11 |
| Cohort | 11 |
| CO | 11 |
| CE | 11 |
| BAME | 11 |
| ATP | 11 |
| ACE-2 | 11 |
| ACE | 11 |
| MRI | 11 |
| Ill | 11 |
| Quality | 11 |
| Outbreak | 11 |
| Overweight | 11 |
| pH | 11 |
| lymphopenia | 11 |
| chi | 11 |
| Viral | 11 |
| UC | 11 |
| Trial | 11 |
| State | 11 |
| Seroprevalence | 11 |
| Scientific | 11 |
| SI | 11 |
| S3 | 11 |
| Ritonavir | 11 |
| Portugal | 11 |
| Poisson | 11 |
| PAI-1 | 11 |
| Endotics | 10 |
| ECMO | 10 |
| EDs | 10 |
| Early | 10 |
| HR1 | 10 |
| Exosomes | 10 |
| Fire | 10 |
| Grover | 10 |
| HKU1 | 10 |
| Digital | 10 |
| SEMI | 10 |
| Diagnostic | 10 |
| College | 10 |
| Classification | 10 |
| Cancer | 10 |
| Canada | 10 |
| CDC | 10 |
| Brigade | 10 |
| Author | 10 |
| America | 10 |
| Abbvie | 10 |
| Laboratory | 10 |
| Hydroxychloroquine | 10 |
| min | 10 |
| Life | 10 |
| Student | 10 |
| multicentre | 10 |
| i | 10 |
| homotrimer | 10 |
| Women | 10 |
| West | 10 |
| Version | 10 |
| Vero | 10 |
| Unit | 10 |
| TCA | 10 |
| Likert | 10 |
| Rhinovirus | 10 |
| Perceived | 10 |
| Paris | 10 |
| PS | 10 |
| Organ | 10 |
| Observational | 10 |
| Motor | 10 |
| Mental | 10 |
| Long | 10 |
| Province | 10 |
| Guide | 9 |
| Enzyme | 9 |
| Failure | 9 |
| Features | 9 |
| G | 9 |
| GGT | 9 |
| Hypoxemia | 9 |
| Healthcare | 9 |
| Hsp | 9 |
| Huanan | 9 |
| Hypertension | 9 |
| DIF | 9 |
| IL | 9 |
| IL-5 | 9 |
| Effect | 9 |
| Cases | 9 |
| Comorbidity | 9 |
| Commission | 9 |
| CoV2 | 9 |
| Chitosan | 9 |
| Cambridge | 9 |
| COVID-2019 | 9 |
| CH | 9 |
| CENTER | 9 |
| CD26 | 9 |
| IV | 9 |
| Baseline | 9 |
| BMCA | 9 |
| B. | 9 |
| Antibodies | 9 |
| Ang2 | 9 |
| Big | 9 |
| Influenza | 9 |
| Inhibitors | 9 |
| Republic | 9 |
| −1 | 9 |
| γ | 9 |
| range | 9 |
| del | 9 |
| U.S. | 9 |
| Institutional | 9 |
| Support | 9 |
| Studies | 9 |
| Spanish | 9 |
| Social | 9 |
| September | 9 |
| San | 9 |
| Reviews | 9 |
| Resveratrol | 9 |
| Traumatic | 9 |
| Renin | 9 |
| Mortality | 9 |
| Randomized | 9 |
| KAP | 9 |
| L. | 9 |
| MMAT | 9 |
| Monitoring | 9 |
| LOC | 9 |
| Nrf2 | 9 |
| P1 | 9 |
| Pearson | 9 |
| Pharma | 9 |
| Predictors | 9 |
| Pregnancy | 9 |
| GDM | 8 |
| EF | 8 |
| ER | 8 |
| ERT | 8 |
| EV | 8 |
| Ethics | 8 |
| FDP | 8 |
| Force | 8 |
| Francesco | 8 |
| IgE | 8 |
| Government | 8 |
| I. | 8 |
| IHC | 8 |
| IL-1 | 8 |
| IL-2 | 8 |
| IVMP | 8 |
| Imaging | 8 |
| Infectious | 8 |
| Diagnosis | 8 |
| E6 | 8 |
| Interventions | 8 |
| Detection | 8 |
| Desitin | 8 |
| Acute | 8 |
| Aldosterone | 8 |
| Andrea | 8 |
| August | 8 |
| Azithromycin | 8 |
| Based | 8 |
| CD4 | 8 |
| CIT | 8 |
| CNS | 8 |
| CRC | 8 |
| CS | 8 |
| Charlson | 8 |
| Chest | 8 |
| Chicago | 8 |
| Coagulopathy | 8 |
| Cochrane | 8 |
| Critically | 8 |
| Initiative | 8 |
| OC43 | 8 |
| Invendoscope | 8 |
| Return | 8 |
| STAI | 8 |
| Science | 8 |
| Series | 8 |
| Singapore | 8 |
| Sirolimus | 8 |
| Switzerland | 8 |
| TMPRSS2 | 8 |
| Technologies | 8 |
| Thailand | 8 |
| UCB | 8 |
| UPDRS | 8 |
| mTOR | 8 |
| metformin | 8 |
| miRNAs | 8 |
| oro | 8 |
| square | 8 |
| Iran | 8 |
| SAMS | 8 |
| Task | 8 |
| Reporting | 8 |
| NY | 8 |
| Qualitative | 8 |
| MBI | 8 |
| MVs | 8 |
| Materials | 8 |
| Methods | 8 |
| Mitophagy | 8 |
| Movement | 8 |
| NMS | 8 |
| Language | 8 |
| NYHA | 8 |
| Peripapillary | 8 |
| Prospective | 8 |
| Population | 8 |
| Protein | 8 |
| P4 | 8 |
| ORF1ab | 8 |
| ε | 8 |
| HDAC | 7 |
| Environment | 7 |
| Epidemiological | 7 |
| Epidural | 7 |
| Extracellular | 7 |
| France | 7 |
| GISAID | 7 |
| German | 7 |
| HCQ | 7 |
| IL-4 | 7 |
| Hong | 7 |
| IBS | 7 |
| ID | 7 |
| Donor | 7 |
| IP-10 | 7 |
| Induced | 7 |
| Information | 7 |
| Interval | 7 |
| Jung | 7 |
| Employment | 7 |
| ALS | 7 |
| Diego | 7 |
| Biliary | 7 |
| La | 7 |
| AT1R | 7 |
| Angiogenesis | 7 |
| Antibody | 7 |
| Area | 7 |
| Balance | 7 |
| Bayer | 7 |
| Bial | 7 |
| Brief | 7 |
| Dental | 7 |
| Cap | 7 |
| Cognitive | 7 |
| Collaborative | 7 |
| Coma | 7 |
| Critical | 7 |
| DCs | 7 |
| Daegu | 7 |
| Daniel | 7 |
| Kong | 7 |
| High | 7 |
| Liguria | 7 |
| Roche | 7 |
| SINAVE | 7 |
| STAT3 | 7 |
| Short | 7 |
| Software | 7 |
| Summary | 7 |
| Taiwan | 7 |
| Technology | 7 |
| Term | 7 |
| Th17 | 7 |
| Transfer | 7 |
| Units | 7 |
| Zambon | 7 |
| disease | 7 |
| exosomes | 7 |
| monocyte | 7 |
| rt | 7 |
| ® | 7 |
| × | 7 |
| MDC | 7 |
| SCIM | 7 |
| Workers | 7 |
| Questionnaire | 7 |
| P | 7 |
| Market | 7 |
| Q | 7 |
| Mouse | 7 |
| Netherlands | 7 |
| Network | 7 |
| Nucleocapsid | 7 |
| Nursing | 7 |
| OXPHOS | 7 |
| Non | 7 |
| PDB | 7 |
| PIC | 7 |
| PPE | 7 |
| PT | 7 |
| Paclitaxel | 7 |
| Pathogenesis | 7 |
| P6 | 7 |
| Preventive | 7 |
| Pathway | 7 |
| Dysfunction | 6 |
| Factor | 6 |
| Genova | 6 |
| Geneva | 6 |
| García | 6 |
| Function | 6 |
| EndoRings | 6 |
| Everolimus | 6 |
| Ethical | 6 |
| Endocuff | 6 |
| EU | 6 |
| H | 6 |
| E. | 6 |
| GraphPad | 6 |
| IT | 6 |
| HCl | 6 |
| Hsp60 | 6 |
| Hz | 6 |
| IBM | 6 |
| ICUs | 6 |
| IL-13 | 6 |
| IOP | 6 |
| IRB | 6 |
| Illness | 6 |
| Immunohistochemistry | 6 |
| Integrated | 6 |
| Intubation | 6 |
| Disorder | 6 |
| Item | 6 |
| Dr. | 6 |
| Austria | 6 |
| Digitimer | 6 |
| CMOS | 6 |
| K | 6 |
| 6MWD | 6 |
| 6MWT | 6 |
| ADE | 6 |
| AG | 6 |
| AMPK | 6 |
| Alzheimer | 6 |
| Angiography | 6 |
| Anxiety | 6 |
| Barcelona | 6 |
| Behavioral | 6 |
| Blockers | 6 |
| Bonferroni | 6 |
| COPE | 6 |
| Deutschland | 6 |
| COVID19 | 6 |
| CXCL8 | 6 |
| Central | 6 |
| Chilblain | 6 |
| Comorbidities | 6 |
| Complex | 6 |
| Controlled | 6 |
| Corona | 6 |
| Coronaviridae | 6 |
| Corp. | 6 |
| Cronbach | 6 |
| DPP4i | 6 |
| David | 6 |
| JAAM | 6 |
| PubMed | 6 |
| KTx | 6 |
| SMA | 6 |
| Savana | 6 |
| Seafood | 6 |
| Sepsis | 6 |
| Severity | 6 |
| TSLP | 6 |
| Taste | 6 |
| Tomography | 6 |
| Tris | 6 |
| U | 6 |
| VO | 6 |
| Vascular | 6 |
| Vienna | 6 |
| Vircell | 6 |
| WCE | 6 |
| Weight | 6 |
| Wilk | 6 |
| cardiomyocyte | 6 |
| darunavir | 6 |
| doc_id | 6 |
| enzyme-2 | 6 |
| kg | 6 |
| lopinavir | 6 |
| mRNA | 6 |
| miRNA | 6 |
| mitophagy | 6 |
| pg | 6 |
| pmol | 6 |
| Lancet | 6 |
| βCoV | 6 |
| SPECT | 6 |
| Yang | 6 |
| SIRT | 6 |
| O | 6 |
| Limburg | 6 |
| Lopinavir | 6 |
| SBVS | 6 |
| MV | 6 |
| Madrid | 6 |
| Manual | 6 |
| Maria | 6 |
| Mechanical | 6 |
| Mice | 6 |
| Ministry | 6 |
| Mitochondria | 6 |
| NHW | 6 |
| NeoGuide | 6 |
| Measures | 6 |
| Outcome | 6 |
| Program | 6 |
| Region | 6 |
| RTI | 6 |
| ROI | 6 |
| Retrospective | 6 |
| RAS | 6 |
| Preliminary | 6 |
| Post | 6 |
| Parathyroid | 6 |
| PDR | 6 |
| P2 | 6 |
| Registry | 6 |
| ISTH | 5 |
| Gut | 5 |
| IL10 | 5 |
| IL-8 | 5 |
| IL-33 | 5 |
| Healthy | 5 |
| HIV-1 | 5 |
| H.N. | 5 |
| Free | 5 |
| Guideline | 5 |
| Giovanni | 5 |
| GHQ | 5 |
| Findings | 5 |
| Frankfurt | 5 |
| Francisco | 5 |
| First | 5 |
| FUSE | 5 |
| Incubation | 5 |
| Imai | 5 |
| Kim | 5 |
| Infected | 5 |
| Jun | 5 |
| MCP-1 | 5 |
| Experimental | 5 |
| Lombardy | 5 |
| Licher | 5 |
| Li | 5 |
| Leptin | 5 |
| Kruskal | 5 |
| Job | 5 |
| Infections | 5 |
| JBI | 5 |
| Items | 5 |
| Isolation | 5 |
| Ischemic | 5 |
| Investigation | 5 |
| Interim | 5 |
| Inflammation | 5 |
| FU | 5 |
| Burden | 5 |
| Excellence | 5 |
| Estimation | 5 |
| Coping | 5 |
| CoV. | 5 |
| Castilla | 5 |
| Carlo | 5 |
| CXCL10 | 5 |
| CVDs | 5 |
| CV | 5 |
| Briefing | 5 |
| Background | 5 |
| BSCS | 5 |
| Autopsy | 5 |
| Asian | 5 |
| Approach | 5 |
| Ang-1 | 5 |
| Americans | 5 |
| Aer | 5 |
| MSCs | 5 |
| Correlation | 5 |
| Cox | 5 |
| Cristina | 5 |
| Discovery | 5 |
| Enterobacteriaceae | 5 |
| Endoscopic | 5 |
| Emerging | 5 |
| Electronic | 5 |
| ESC | 5 |
| EM | 5 |
| Dynamics | 5 |
| Director | 5 |
| Ct | 5 |
| Design | 5 |
| De | 5 |
| Danoprevir | 5 |
| DTT | 5 |
| DPG | 5 |
| D. | 5 |
| Cytokines | 5 |
| MCT | 5 |
| Wallis | 5 |
| Mancha | 5 |
| Secondary | 5 |
| Tool | 5 |
| Tokyo | 5 |
| Time | 5 |
| Thrombosis | 5 |
| Thoracic | 5 |
| Therapeutics | 5 |
| Tai | 5 |
| Tables | 5 |
| TF | 5 |
| TAT | 5 |
| Structure | 5 |
| Statement | 5 |
| Standards | 5 |
| Situation | 5 |
| Silvia | 5 |
| Signaling | 5 |
| Shapiro | 5 |
| Trauma | 5 |
| Trends | 5 |
| Trials | 5 |
| interleukin-6 | 5 |
| Mary | 5 |
| protein-1 | 5 |
| omalizumab | 5 |
| neutrophilic | 5 |
| mtDNA | 5 |
| los | 5 |
| levodopa | 5 |
| committee | 5 |
| Univariate | 5 |
| colonoscope | 5 |
| ang | 5 |
| analysis | 5 |
| aa | 5 |
| Zika | 5 |
| 5 | |
| Warsaw | 5 |
| Selamectin | 5 |
| angiotensin-1 | 5 |
| Second | 5 |
| PEER | 5 |
| Outpatient | 5 |
| Organisation | 5 |
| OR | 5 |
| OCTA | 5 |
| Notch1 | 5 |
| Neutrophilic | 5 |
| Neurological | 5 |
| Networks | 5 |
| NaviCam | 5 |
| Nagelkerke | 5 |
| NCBI | 5 |
| Myocardial | 5 |
| Municipal | 5 |
| Mixed | 5 |
| Material | 5 |
| STROBE | 5 |
| Maslach | 5 |
| Overview | 5 |
| N. | 5 |
| PI3K | 5 |
| R. | 5 |
| S6 | 5 |
| Paediatric | 5 |
| SAS | 5 |
| Royal | 5 |
| Response | 5 |
| Resource | 5 |
| RdRp | 5 |
| Radial | 5 |
| Rome | 5 |
| Psychological | 5 |
| Power | 5 |
| Protection | 5 |
| Prediction | 5 |
| Pediatric | 5 |
| Prasad | 5 |
| Performance | 5 |
| FiO | 4 |
| French | 4 |
| Friedman | 4 |
| GBVI | 4 |
| GE | 4 |
| Hematological | 4 |
| GROMACS | 4 |
| Ig | 4 |
| Hiroshi | 4 |
| IL-17A | 4 |
| IL6 | 4 |
| Epstein | 4 |
| IP10 | 4 |
| Fernández | 4 |
| Disability | 4 |
| Epidemic | 4 |
| EAPC | 4 |
| Drug | 4 |
| Domain | 4 |
| Distribution | 4 |
| Disparities | 4 |
| Diagnostics | 4 |
| Determinants | 4 |
| Depression | 4 |
| Density | 4 |
| Deaths | 4 |
| DBC | 4 |
| Inhibitor | 4 |
| Czech | 4 |
| Ingelheim | 4 |
| MAS | 4 |
| Innate | 4 |
| Inpatient | 4 |
| CsA | 4 |
| Montreal | 4 |
| Milan | 4 |
| Men | 4 |
| Medicare | 4 |
| Mazowieckie | 4 |
| Marco | 4 |
| Manchester | 4 |
| Macario | 4 |
| MSD | 4 |
| MLE | 4 |
| MCP1 | 4 |
| Lymphopenia | 4 |
| Lombardia | 4 |
| Locus | 4 |
| Living | 4 |
| Livedo | 4 |
| Linton | 4 |
| Learning | 4 |
| LIMCs | 4 |
| LDH | 4 |
| Kingdom | 4 |
| Keiser | 4 |
| José | 4 |
| JS | 4 |
| Istituto | 4 |
| Invendoscopy | 4 |
| Cytokine | 4 |
| Atlas | 4 |
| Criteria | 4 |
| Bias | 4 |
| Beneficiaries | 4 |
| Ben | 4 |
| Beijing | 4 |
| Bcl-2 | 4 |
| Barbara | 4 |
| BALF | 4 |
| Assay | 4 |
| Applications | 4 |
| Application | 4 |
| Andrei | 4 |
| Analyses | 4 |
| Amber | 4 |
| Alphacoronavirus | 4 |
| Allergic | 4 |
| Alberto | 4 |
| Akhmetzhanov | 4 |
| Agency | 4 |
| Africa | 4 |
| Administration | 4 |
| Activity | 4 |
| AbbVie | 4 |
| AST | 4 |
| ALT | 4 |
| AA | 4 |
| A1 | 4 |
| 3c | 4 |
| Movie | 4 |
| Betacoronavirus | 4 |
| Blood | 4 |
| Corticosteroid | 4 |
| Body | 4 |
| Consensus | 4 |
| Conditions | 4 |
| Community | 4 |
| CoVZXC21 | 4 |
| Co | 4 |
| Clínic | 4 |
| Cluster | 4 |
| Clostridioides | 4 |
| Chloroquine | 4 |
| Chinese | 4 |
| Chemical | 4 |
| Challenge | 4 |
| Cellular | 4 |
| Casas | 4 |
| Carsten | 4 |
| Cappello | 4 |
| Capillary | 4 |
| California | 4 |
| CTC | 4 |
| CPET | 4 |
| COVID-19-induced | 4 |
| COV-2 | 4 |
| CORONADO | 4 |
| CD | 4 |
| CBD | 4 |
| C3 | 4 |
| Boehringer | 4 |
| Mount | 4 |
| MAPK | 4 |
| Multicenter | 4 |
| Telemedicine | 4 |
| Video | 4 |
| Vesicles | 4 |
| Varelli | 4 |
| VISION | 4 |
| VEGF | 4 |
| Ultrasound | 4 |
| Troponin | 4 |
| Treg | 4 |
| Trait | 4 |
| Tocilizumab | 4 |
| Therapies | 4 |
| Tests | 4 |
| Teleorthodontics | 4 |
| Team | 4 |
| Services | 4 |
| Strategy | 4 |
| Standardization | 4 |
| Standard | 4 |
| Square | 4 |
| Sputum | 4 |
| Spread | 4 |
| Spectrum | 4 |
| SpO2 | 4 |
| Sirtuins | 4 |
| Sirtuin-1 | 4 |
| Sirtuin | 4 |
| Sirt1 | 4 |
| Sinai | 4 |
| WSA | 4 |
| Wang | 4 |
| Wholesale | 4 |
| Working | 4 |
| NF | 4 |
| κB | 4 |
| remdesivir | 4 |
| protein | 4 |
| placentae | 4 |
| nucleocapsid | 4 |
| nsp14 | 4 |
| naso | 4 |
| livedo | 4 |
| inotropes | 4 |
| inflammasome | 4 |
| histopathological | 4 |
| health | 4 |
| group | 4 |
| el | 4 |
| ectasia | 4 |
| eHealth | 4 |
| coronavirus-2 | 4 |
| cm | 4 |
| chemoattractant | 4 |
| anti | 4 |
| anakinra | 4 |
| alfa | 4 |
| airway | 4 |
| abruptio | 4 |
| Young | 4 |
| Wu | 4 |
| Signal | 4 |
| pO2 | 4 |
| Sensitivity | 4 |
| Preferred | 4 |
| Prague | 4 |
| Position | 4 |
| Policlinico | 4 |
| Pilot | 4 |
| PillCam | 4 |
| Phenotype | 4 |
| Pfizer | 4 |
| Pathways | 4 |
| Paolo | 4 |
| Palliative | 4 |
| PFS | 4 |
| PBS | 4 |
| P8 | 4 |
| Origin | 4 |
| Opening | 4 |
| ≥3 | 4 |
| Obesity | 4 |
| ORF3b | 4 |
| ONS | 4 |
| Nishiura | 4 |
| Nintendo | 4 |
| Neurokinex | 4 |
| Natalie | 4 |
| NSE | 4 |
| NLP | 4 |
| NHS | 4 |
| SelaMeerin | 4 |
| Precision | 4 |
| NP | 4 |
| Presenting | 4 |
| Remdesivir | 4 |
| Section | 4 |
| Prevalence | 4 |
| Scooter | 4 |
| Savona | 4 |
| SRT2104 | 4 |
| SDOH | 4 |
| S5 | 4 |
| S4 | 4 |
| S.B. | 4 |
| Ruminococcaceae | 4 |
| Reproduction | 4 |
| Renal | 4 |
| Score | 4 |
| Remarks | 4 |
| RC | 4 |
| Primary | 4 |
| Prof. | 4 |
| Regulation | 4 |
| R(0 | 4 |
| RAD001 | 4 |
| Seegene | 4 |
| RCPCH | 4 |
| Recurrent | 4 |
| Recipient | 4 |
| Recommendations | 4 |
| Rating | 4 |
| Rapid | 4 |
| GROUCH | 3 |
| GS | 3 |
| Garden | 3 |
| Gastrocnemius | 3 |
| Gastroenterology | 3 |
| Groups | 3 |
| Genomic | 3 |
| Giuseppe | 3 |
| Glaucoma | 3 |
| Good | 3 |
| Groningen | 3 |
| Gene | 3 |
| H. | 3 |
| Growth | 3 |
| Histologic | 3 |
| HCV | 3 |
| HCoV-229E | 3 |
| HEK293F | 3 |
| HPAI | 3 |
| HRQoL | 3 |
| HRafter | 3 |
| HTN | 3 |
| Handbook | 3 |
| Hematoxylin | 3 |
| GP | 3 |
| Hertfordshire | 3 |
| HLA | 3 |
| Eosinophils | 3 |
| GCSF | 3 |
| GA | 3 |
| EBV | 3 |
| Hopkins | 3 |
| EC | 3 |
| ECOG | 3 |
| ECP | 3 |
| EMEM | 3 |
| EMR | 3 |
| EVs | 3 |
| El | 3 |
| Elena | 3 |
| Elizabeth | 3 |
| Embase | 3 |
| Embryology | 3 |
| Engineering | 3 |
| Entry | 3 |
| Erin | 3 |
| F.C. | 3 |
| FGF | 3 |
| Faculty | 3 |
| Faecal | 3 |
| Favipiravir | 3 |
| File | 3 |
| Fitness | 3 |
| Fumigatus | 3 |
| G.L.V. | 3 |
| Histone | 3 |
| KGF | 3 |
| Humoral | 3 |
| Hyperinflammatory | 3 |
| Klucken | 3 |
| Knowledge | 3 |
| LSD | 3 |
| LTC | 3 |
| Labour | 3 |
| Laura | 3 |
| Lee | 3 |
| Lesions | 3 |
| Levels | 3 |
| Literature | 3 |
| Liver | 3 |
| Liverpool | 3 |
| London | 3 |
| Loss | 3 |
| Ls | 3 |
| Luis | 3 |
| Luminex | 3 |
| Lupus | 3 |
| Lysosomal | 3 |
| MIBI | 3 |
| ML | 3 |
| MLHFQ | 3 |
| MO | 3 |
| MOE | 3 |
| Dysphagia | 3 |
| Kinoshita | 3 |
| K.G. | 3 |
| Juan | 3 |
| Iceland | 3 |
| ICS | 3 |
| IL-1β | 3 |
| IL-25 | 3 |
| IL-2R | 3 |
| IL1β | 3 |
| IL2 | 3 |
| IL7 | 3 |
| IL8 | 3 |
| IMET | 3 |
| IPD | 3 |
| IPF | 3 |
| IgG. | 3 |
| Josep | 3 |
| IgM+IgA | 3 |
| Immunology | 3 |
| Inhibition | 3 |
| Intuitive | 3 |
| Invendo | 3 |
| Inventory | 3 |
| Involvement | 3 |
| Italiana | 3 |
| Italians | 3 |
| Javier | 3 |
| Johns | 3 |
| Dysregulation | 3 |
| Bronchial | 3 |
| Disorders | 3 |
| Antonio | 3 |
| Approaches | 3 |
| Arabia | 3 |
| Armonk | 3 |
| Asia | 3 |
| Aspergillus | 3 |
| Assisted | 3 |
| Attitudes | 3 |
| Autophagy | 3 |
| BD | 3 |
| BDI | 3 |
| BLS | 3 |
| Bank | 3 |
| Bassetti | 3 |
| Bat | 3 |
| Bayes | 3 |
| Belgium | 3 |
| Binding | 3 |
| Biomedical | 3 |
| Bland | 3 |
| Bowel | 3 |
| Brazil | 3 |
| Breast | 3 |
| MSM | 3 |
| C.P. | 3 |
| CCL11 | 3 |
| Apios | 3 |
| Antiphospholipid | 3 |
| Differences | 3 |
| Anterior | 3 |
| 3D | 3 |
| 3a | 3 |
| 3d | 3 |
| A2 | 3 |
| AAs | 3 |
| ACA | 3 |
| ACEi | 3 |
| ADM | 3 |
| AHA | 3 |
| AIDS | 3 |
| ALP | 3 |
| AMBU | 3 |
| APOS | 3 |
| ASP | 3 |
| AZ | 3 |
| Achilles | 3 |
| Act | 3 |
| Adherence | 3 |
| Alex | 3 |
| Allplex | 3 |
| Alpha | 3 |
| Altman | 3 |
| An | 3 |
| Andalusia | 3 |
| Ang | 3 |
| CCL2 | 3 |
| CCL3 | 3 |
| CCL5 | 3 |
| CCT | 3 |
| ColonoSight | 3 |
| Colonoscopy | 3 |
| Commitment | 3 |
| Complications | 3 |
| Comprehensive | 3 |
| Concept | 3 |
| Contact | 3 |
| Controls | 3 |
| Convalescent | 3 |
| Converting | 3 |
| Copenhagen | 3 |
| Council | 3 |
| Cov2 | 3 |
| Crohn | 3 |
| Cross | 3 |
| Cycle | 3 |
| DAMPs | 3 |
| DBS | 3 |
| DCS | 3 |
| DNA | 3 |
| DT | 3 |
| Dallas | 3 |
| Deltacoronavirus | 3 |
| Dermatology | 3 |
| Diabetes | 3 |
| Colitis | 3 |
| Coherence | 3 |
| CoV-2-specific | 3 |
| Carlos | 3 |
| CD147 | 3 |
| CD25 | 3 |
| CD38 | 3 |
| CFDA | 3 |
| CMV | 3 |
| COVID- | 3 |
| CXRs | 3 |
| Ca | 3 |
| Capacity | 3 |
| Capsule | 3 |
| Cardiothoracic | 3 |
| Cary | 3 |
| CoV-1 | 3 |
| Casa | 3 |
| Caudovirales | 3 |
| Characterization | 3 |
| Chattanooga | 3 |
| Chemokine | 3 |
| Chiara | 3 |
| Childhood | 3 |
| Chlamydia | 3 |
| Cigarette | 3 |
| Circulatory | 3 |
| Clara | 3 |
| MOF | 3 |
| Advanced | 3 |
| MT | 3 |
| Taxonomy | 3 |
| Teff | 3 |
| Testing | 3 |
| Texas | 3 |
| Th2 | 3 |
| Thomas | 3 |
| Thrombocytopenia | 3 |
| Thromboembolic | 3 |
| Times | 3 |
| Tino | 3 |
| Tor | 3 |
| Toronto | 3 |
| Travel | 3 |
| Tucson | 3 |
| U.S | 3 |
| UPR | 3 |
| Ulcerative | 3 |
| Umbilical | 3 |
| Underlying | 3 |
| Union | 3 |
| Universal | 3 |
| VTE | 3 |
| Validation | 3 |
| Validity | 3 |
| Van | 3 |
| Ventana | 3 |
| Technical | 3 |
| Target | 3 |
| Vergata | 3 |
| TNFα | 3 |
| Selected | 3 |
| Selection | 3 |
| Self | 3 |
| Sendai | 3 |
| Seoul | 3 |
| Sera | 3 |
| Sexuality | 3 |
| Shanghai | 3 |
| Sharing | 3 |
| Shock | 3 |
| Single | 3 |
| SirT1 | 3 |
| Sliker | 3 |
| Smell | 3 |
| Solid | 3 |
| Srl | 3 |
| Staphylococcus | 3 |
| Stromal | 3 |
| Sung | 3 |
| Suppression | 3 |
| Surgical | 3 |
| Surveillance | 3 |
| Syncytial | 3 |
| Sánchez | 3 |
| T.K. | 3 |
| Ventricular | 3 |
| Vision | 3 |
| Saudi | 3 |
| hydratase | 3 |
| kcal | 3 |
| key | 3 |
| lymphocytopenia | 3 |
| mA | 3 |
| mM | 3 |
| mTORi | 3 |
| mok | 3 |
| monocarboxypetidase | 3 |
| mt | 3 |
| niveles | 3 |
| para | 3 |
| pneumocytes | 3 |
| pp1a | 3 |
| pp1ab | 3 |
| tele | 3 |
| tensin | 3 |
| thiazolidinediones | 3 |
| trans | 3 |
| vivo | 3 |
| Ξ | 3 |
| β1 | 3 |
| − | 3 |
| −3 | 3 |
| ≥5 | 3 |
| Machine | 3 |
| inotropic | 3 |
| hematoxylin | 3 |
| Volti | 3 |
| grey | 3 |
| WEKA | 3 |
| Water | 3 |
| Welwyn | 3 |
| Workplace | 3 |
| Yichi | 3 |
| Youden | 3 |
| Zhou | 3 |
| Ziekenhuis | 3 |
| ageusia | 3 |
| americana | 3 |
| angiotensin | 3 |
| angiotensinogen | 3 |
| anterior | 3 |
| bat | 3 |
| betacoronaviruses | 3 |
| bronchoalveolar | 3 |
| cardiopathy | 3 |
| coronaropathy | 3 |
| coronaviruses | 3 |
| cortex | 3 |
| defervescence | 3 |
| di | 3 |
| disease-2019 | 3 |
| everolimus | 3 |
| fumarate | 3 |
| Seattle | 3 |
| Zheng | 3 |
| Sars | 3 |
| Nationwide | 3 |
| Neural | 3 |
| NeuroTrauma | 3 |
| Neurologic | 3 |
| Neuromuscular | 3 |
| Neurophysiological | 3 |
| Nicoletta | 3 |
| Nile | 3 |
| Nowcasting | 3 |
| Nuclear | 3 |
| Number | 3 |
| ORF | 3 |
| Occupational | 3 |
| Odds | 3 |
| Omalizumab | 3 |
| Oost | 3 |
| Operating | 3 |
| Optic | 3 |
| Overall | 3 |
| PDGF | 3 |
| PI3 | 3 |
| PRR | 3 |
| PTM | 3 |
| Padova | 3 |
| ParkinsonNet | 3 |
| Parkinson´s | 3 |
| Natriuretic | 3 |
| NVI-25 | 3 |
| Pathophysiology | 3 |
| NK | 3 |
| Manager | 3 |
| Sara | 3 |
| Manuel | 3 |
| Marcos | 3 |
| Marina | 3 |
| Martin | 3 |
| María | 3 |
| Massimo | 3 |
| Matteo | 3 |
| Mechanism | 3 |
| Mechanisms | 3 |
| Media | 3 |
| Medication | 3 |
| Medikus | 3 |
| Merck | 3 |
| Metabolic | 3 |
| Metformin | 3 |
| Microbiology | 3 |
| Microvesicles | 3 |
| MoCa | 3 |
| ModelFinder | 3 |
| Montpellier | 3 |
| Motol | 3 |
| Multi | 3 |
| NC | 3 |
| Pathology | 3 |
| NIV | 3 |
| People | 3 |
| Related | 3 |
| Remote | 3 |
| Reports | 3 |
| Rescue | 3 |
| Resistant | 3 |
| Responses | 3 |
| Reticularis | 3 |
| Retina | 3 |
| Retinal | 3 |
| Rex | 3 |
| Ricardo | 3 |
| Rift | 3 |
| Roja | 3 |
| Ryo | 3 |
| S.M. | 3 |
| SAVANA | 3 |
| SC40 | 3 |
| SCL-90 | 3 |
| SEIR | 3 |
| SEROCoV | 3 |
| SIRT1-targeted | 3 |
| SPID | 3 |
| SVH | 3 |
| Period | 3 |
| Safety | 3 |
| Santa | 3 |
| Relation | 3 |
| Rio | 3 |
| Reinhard | 3 |
| Prism | 3 |
| Philips | 3 |
| Peripheral | 3 |
| Pisa | 3 |
| Regulator | 3 |
| Placebo | 3 |
| Plasma | 3 |
| Polyps | 3 |
| Posterior | 3 |
| Praevia | 3 |
| Preconception | 3 |
| Prehospital | 3 |
| Prell | 3 |
| Practical | 3 |
| Ratio | 3 |
| Psychology | 3 |
| Psychometric | 3 |
| RBM | 3 |
| Recovery | 3 |
| RMSF | 3 |
| Racial | 3 |
| Regional | 3 |
| Recognition | 3 |
| Recall | 3 |
| Psychiatry | 3 |
| Hygiene | 2 |
| Hydraulic | 2 |
| Ho | 2 |
| Holm | 2 |
| Heparin | 2 |
| Hematologic | 2 |
| Hokkaido | 2 |
| Hoon | 2 |
| Home | 2 |
| Homotrimer | 2 |
| Huh7 | 2 |
| Humans | 2 |
| Huntington | 2 |
| Hansa | 2 |
| Hayashi | 2 |
| HCMV | 2 |
| Hannah | 2 |
| Hamstring | 2 |
| Ham | 2 |
| HTCC | 2 |
| HRbefore | 2 |
| HRP | 2 |
| HIMCs | 2 |
| HIF-1α | 2 |
| HE | 2 |
| HCB/2020/0581 | 2 |
| H9N5 | 2 |
| H5N1 | 2 |
| H&E | 2 |
| IBV | 2 |
| H2020 | 2 |
| I.B. | 2 |
| Inclusion | 2 |
| ICAM-1 | 2 |
| ImageNet | 2 |
| Induction | 2 |
| Gynecology | 2 |
| Individual | 2 |
| Indicators | 2 |
| Indiana | 2 |
| India | 2 |
| Independence | 2 |
| Imputation | 2 |
| Improvement | 2 |
| Important | 2 |
| Implications | 2 |
| Impairment | 2 |
| Immunosuppression | 2 |
| Immunoglobulin | 2 |
| Idiopathic | 2 |
| ICT | 2 |
| Ideation | 2 |
| Iaccarino | 2 |
| ISO | 2 |
| ISI | 2 |
| INR | 2 |
| IMV | 2 |
| IL1 | 2 |
| IGC | 2 |
| IFITM | 2 |
| IEMEST | 2 |
| IEM | 2 |
| IDSA | 2 |
| IDS | 2 |
| ICTV | 2 |
| Gómez | 2 |
| Farré | 2 |
| Guillain | 2 |
| Federica | 2 |
| Functions | 2 |
| Frieling | 2 |
| Frank | 2 |
| Francesca | 2 |
| Fractional | 2 |
| Fourth | 2 |
| Formosa | 2 |
| Forest | 2 |
| Forces | 2 |
| Font | 2 |
| Florence | 2 |
| Five | 2 |
| Field | 2 |
| FiO2 | 2 |
| Feasibility | 2 |
| Funding | 2 |
| FcγR | 2 |
| Fat | 2 |
| Fast | 2 |
| Family | 2 |
| Fallbrook | 2 |
| Facility | 2 |
| 2 | |
| Fabry | 2 |
| FBS | 2 |
| F. | 2 |
| Eye | 2 |
| Extended | 2 |
| Exposure | 2 |
| Infrastructure | 2 |
| Funders | 2 |
| Fundus | 2 |
| Guangdong | 2 |
| Gaucher | 2 |
| Grünenthal | 2 |
| 2 | |
| González | 2 |
| Gloucestershire | 2 |
| GlaxoSmithKline | 2 |
| Giuseppina | 2 |
| Giulia | 2 |
| Gini | 2 |
| Gilead | 2 |
| Gianluca | 2 |
| Georgia | 2 |
| Genk | 2 |
| Generalized | 2 |
| GenBank | 2 |
| Garcia | 2 |
| Future | 2 |
| Gao | 2 |
| Gan | 2 |
| Gammazza | 2 |
| Gammacoronavirus | 2 |
| Gamma | 2 |
| Games | 2 |
| Galván | 2 |
| Gain | 2 |
| GSCF | 2 |
| GPs | 2 |
| GMP | 2 |
| GEE | 2 |
| GATA-4 | 2 |
| G1 | 2 |
| Inflammasome | 2 |
| McDonagh | 2 |
| Ingmar | 2 |
| MERS)-may | 2 |
| M.E.M | 2 |
| M.K. | 2 |
| M.S. | 2 |
| MA | 2 |
| MCP-3 | 2 |
| MEGA | 2 |
| MERS- | 2 |
| Initial | 2 |
| MHC | 2 |
| MIP | 2 |
| MIP-1A | 2 |
| MRSA | 2 |
| Maas | 2 |
| Mac | 2 |
| Lymphoid | 2 |
| Lymphocytes | 2 |
| Lymphocyte | 2 |
| Lumbar | 2 |
| Lucinda | 2 |
| Low | 2 |
| Los | 2 |
| Lorrain | 2 |
| Lorenzo | 2 |
| Lorenzl | 2 |
| Longitudinal | 2 |
| Lodi | 2 |
| Lin | 2 |
| Like | 2 |
| Library | 2 |
| Leung | 2 |
| Leukocyte | 2 |
| Macrophage | 2 |
| Magnetic | 2 |
| Main | 2 |
| Melissa | 2 |
| Minnesota | 2 |
| Min | 2 |
| Mild | 2 |
| Milano | 2 |
| Miguel | 2 |
| Microbiome | 2 |
| Michele | 2 |
| Michael | 2 |
| Mexico | 2 |
| Methylprednisolone | 2 |
| Method | 2 |
| Metchnikoff | 2 |
| Metapneumovirus | 2 |
| Memory | 2 |
| Melinta | 2 |
| Mandall | 2 |
| Melatonin | 2 |
| Medline | 2 |
| Mediterranean | 2 |
| Medicines | 2 |
| Measurement | 2 |
| Exosome | 2 |
| Mayhew | 2 |
| Mast | 2 |
| Mass | 2 |
| Martín | 2 |
| Martí | 2 |
| Marino | 2 |
| Manzoni | 2 |
| Manifestations | 2 |
| Letovirinae | 2 |
| Legionellosis | 2 |
| League | 2 |
| Intestinal | 2 |
| Jan | 2 |
| JMP | 2 |
| JL | 2 |
| JHM | 2 |
| JASP | 2 |
| JAK | 2 |
| Ito | 2 |
| Italia | 2 |
| Ishmael | 2 |
| Iscan | 2 |
| Ion | 2 |
| Invasive | 2 |
| Intravascular | 2 |
| Intimacy | 2 |
| Interpersonal | 2 |
| Janet | 2 |
| Interoperability | 2 |
| Internal | 2 |
| Interferons | 2 |
| Interferon | 2 |
| Interface | 2 |
| Interaction | 2 |
| Intelligent | 2 |
| Intelligence | 2 |
| Integration | 2 |
| Insulin | 2 |
| Institutes | 2 |
| 2 | |
| Innovation | 2 |
| Injured | 2 |
| Janeiro | 2 |
| January-10 | 2 |
| Layer | 2 |
| Kit | 2 |
| Law | 2 |
| Lars | 2 |
| Lane | 2 |
| Laboratories | 2 |
| LSDs | 2 |
| LRR | 2 |
| LHam | 2 |
| LCIG | 2 |
| LA | 2 |
| L1 | 2 |
| Kyoto | 2 |
| Krammer | 2 |
| Kolmogorov | 2 |
| Kobayashi | 2 |
| King | 2 |
| Jeong | 2 |
| Khan | 2 |
| Keratinocyte | 2 |
| Kazuhiro | 2 |
| Katsuma | 2 |
| KL-6 | 2 |
| Julio | 2 |
| Judith | 2 |
| Joint | 2 |
| Jodie | 2 |
| Jochen | 2 |
| Joaquín | 2 |
| Joanna | 2 |
| Jin | 2 |
| Jessa | 2 |
| Experience | 2 |
| Collective | 2 |
| ExoN | 2 |
| Bedside | 2 |
| Barr | 2 |
| Barre | 2 |
| Basic | 2 |
| Basilea | 2 |
| Basis | 2 |
| Bayesian | 2 |
| Beer | 2 |
| Excess | 2 |
| Behnke | 2 |
| Bernth | 2 |
| Betacoronaviruses | 2 |
| Beth | 2 |
| Bijak | 2 |
| Bioinformatics | 2 |
| Ball | 2 |
| Backer | 2 |
| BT | 2 |
| BP | 2 |
| BMBF | 2 |
| BIOVIA | 2 |
| BBB | 2 |
| Axelgard | 2 |
| Avian | 2 |
| Avi | 2 |
| Available | 2 |
| Autonomic | 2 |
| Autoantibodies | 2 |
| Audit | 2 |
| Attenuates | 2 |
| Atlanta | 2 |
| Asymptomatic | 2 |
| Biological | 2 |
| Biomarkers | 2 |
| Boards | 2 |
| CHD | 2 |
| CXCL5 | 2 |
| CXCL1 | 2 |
| CSO | 2 |
| CSE | 2 |
| CROS | 2 |
| CPR | 2 |
| COVID-19-free | 2 |
| COVID-19-Related | 2 |
| COVID-19-A | 2 |
| COREQ | 2 |
| CONSISTE | 2 |
| CNI | 2 |
| CIs | 2 |
| CHilblain | 2 |
| CHARMM27 | 2 |
| Bond | 2 |
| CFS | 2 |
| CEIm | 2 |
| CD83 | 2 |
| CD44 | 2 |
| CD3 | 2 |
| CCR5 | 2 |
| CAVE | 2 |
| C1q | 2 |
| Buhmann | 2 |
| Brake | 2 |
| Botox | 2 |
| Bossini | 2 |
| Born | 2 |
| Bone | 2 |
| Astellas | 2 |
| Associations | 2 |
| Assessing | 2 |
| AFI | 2 |
| Adjunctive | 2 |
| Adelaide | 2 |
| Addition | 2 |
| Acral | 2 |
| Acid | 2 |
| Acceptance | 2 |
| Academy | 2 |
| Abrishami | 2 |
| Abortion | 2 |
| Abbreviated | 2 |
| ATG | 2 |
| ARBS | 2 |
| APACHE | 2 |
| AKT | 2 |
| ACTH | 2 |
| Adolescents | 2 |
| ACT | 2 |
| ACC | 2 |
| A.G. | 2 |
| A.F | 2 |
| 6-min | 2 |
| 4.0.0 | 2 |
| 3t0roikx | 2 |
| 1D. | 2 |
| 1.76-fold | 2 |
| 1.14–1.18 | 2 |
| 1.03–1.13 | 2 |
| +33 | 2 |
| +25 | 2 |
| Miro1 | 2 |
| Admission | 2 |
| Adult | 2 |
| Ashbaugh | 2 |
| Annamaria | 2 |
| Artificial | 2 |
| Arrhythmias | 2 |
| Arrest | 2 |
| Arenaviridae | 2 |
| Arch | 2 |
| Appraisal | 2 |
| Appendix | 2 |
| Apache | 2 |
| Análisis | 2 |
| Antonella | 2 |
| Antigen | 2 |
| Antagonists | 2 |
| Annual | 2 |
| Annie | 2 |
| Anna | 2 |
| African | 2 |
| Ankon | 2 |
| Angiotensinogen | 2 |
| Angelini | 2 |
| Anatomy | 2 |
| Anaesthetists | 2 |
| Ameliorates | 2 |
| Ambu | 2 |
| Allergen | 2 |
| Alexander | 2 |
| Alessandro | 2 |
| Akalin | 2 |
| Ahn | 2 |
| Ahmed | 2 |
| Agreement | 2 |
| Capillaries | 2 |
| Cardiovasc | 2 |
| Carolina | 2 |
| EACPR | 2 |
| EVD | 2 |
| ETC | 2 |
| ESHRE | 2 |
| ESH | 2 |
| ESGE | 2 |
| ERS | 2 |
| ERK | 2 |
| ERA | 2 |
| ENE | 2 |
| EMBL | 2 |
| EIT | 2 |
| EHRead | 2 |
| EDI | 2 |
| EBI | 2 |
| E210 | 2 |
| Eastern | 2 |
| E.B. | 2 |
| Dynamic | 2 |
| Duska | 2 |
| Dunbar | 2 |
| Doctors | 2 |
| Dimer | 2 |
| Diet | 2 |
| Dieli | 2 |
| Diagnostico | 2 |
| Diabetic | 2 |
| Di | 2 |
| Devices | 2 |
| Device | 2 |
| Deussen | 2 |
| EXBIO | 2 |
| Echocardiography | 2 |
| Desulfovibrio | 2 |
| Endothelialitis | 2 |
| Exacerbation | 2 |
| Ewald | 2 |
| Everly | 2 |
| Event | 2 |
| España | 2 |
| Escherichia | 2 |
| Erythematosus | 2 |
| Eric | 2 |
| Epidemiologic | 2 |
| Eotaxin | 2 |
| Eosinophil | 2 |
| Environmental | 2 |
| Enterococcus | 2 |
| Enterococci | 2 |
| Endoscope | 2 |
| Ectodomain | 2 |
| Endosc | 2 |
| Endoo | 2 |
| Endoculus | 2 |
| Endocrine | 2 |
| EndoSight | 2 |
| Encephalopathy | 2 |
| Elisabetta | 2 |
| Elie | 2 |
| Elderly | 2 |
| Ehret | 2 |
| Egypt | 2 |
| Eggers | 2 |
| Egger | 2 |
| Effects | 2 |
| Deterioration | 2 |
| Dependent | 2 |
| Carrasco | 2 |
| CoA | 2 |
| Computer | 2 |
| Composition | 2 |
| Complete | 2 |
| Compassion | 2 |
| Comparison | 2 |
| Comparative | 2 |
| Communication | 2 |
| Comment | 2 |
| Colonoscopes | 2 |
| ColonoSleeve | 2 |
| Code | 2 |
| Coagulation | 2 |
| CoV-2-Specific | 2 |
| CoEHAR | 2 |
| Co. | 2 |
| Conceptualization | 2 |
| Ciuti | 2 |
| Cirrus | 2 |
| Circuits | 2 |
| Cidara | 2 |
| Cholangitis | 2 |
| Choi | 2 |
| Chloe | 2 |
| Chimera | 2 |
| Child | 2 |
| Chen | 2 |
| Checklist | 2 |
| Chaperones | 2 |
| Catania | 2 |
| Caruso | 2 |
| Concentration | 2 |
| Consis | 2 |
| Denmark | 2 |
| DBD | 2 |
| Dendritic | 2 |
| Delivery | 2 |
| Dehghani | 2 |
| Defense | 2 |
| Death | 2 |
| Davide | 2 |
| Danail | 2 |
| Daily | 2 |
| Daiichi | 2 |
| DVG | 2 |
| DVC | 2 |
| DRS | 2 |
| DR+ | 2 |
| DGS | 2 |
| DAB | 2 |
| Conway | 2 |
| Cube | 2 |
| Crystal | 2 |
| Cryo | 2 |
| Crespo | 2 |
| Covariates | 2 |
| Country | 2 |
| Costa | 2 |
| Corticosteroids | 2 |
| Correlated | 2 |
| Coronavirus-2 | 2 |
| Coronary | 2 |
| Corno | 2 |
| Coreo | 2 |
| Cooperative | 2 |
| Minority | 2 |
| Head | 2 |
| Mobility | 2 |
| Virology | 2 |
| Venous | 2 |
| Ventilation | 2 |
| Vietnam | 2 |
| View | 2 |
| Vincent | 2 |
| VircellCOVID-19 | 2 |
| Virtual | 2 |
| assistive | 2 |
| Viruses | 2 |
| Vitro | 2 |
| Vivo | 2 |
| Volitional | 2 |
| WAC | 2 |
| Wald | 2 |
| Valvular | 2 |
| Valley | 2 |
| Valentina | 2 |
| Vaccine | 2 |
| VRE | 2 |
| VMD | 2 |
| VE | 2 |
| VCAM-1 | 2 |
| V. | 2 |
| Usefulness | 2 |
| Urticarial | 2 |
| Unprompted | 2 |
| Unknown | 2 |
| Unified | 2 |
| Una | 2 |
| Un | 2 |
| UTR | 2 |
| Waldeyer | 2 |
| Wales | 2 |
| Warnecke | 2 |
| Youth | 2 |
| appendiceal | 2 |
| antiphospholipid | 2 |
| angiopoietin-1 | 2 |
| anchorage | 2 |
| alloantigens | 2 |
| aldosterone | 2 |
| Zhejiang | 2 |
| Zhao | 2 |
| Zeng | 2 |
| Zeiss | 2 |
| Zealand | 2 |
| ZOL | 2 |
| ZC45 | 2 |
| Yuan | 2 |
| Year | 2 |
| Washington | 2 |
| Yates | 2 |
| Y(t | 2 |
| Y | 2 |
| Xbox | 2 |
| X. | 2 |
| Worthington | 2 |
| Wong | 2 |
| Wolz | 2 |
| Wolff | 2 |
| Wireless | 2 |
| Wenzhou | 2 |
| Wellach | 2 |
| Weinheim | 2 |
| Weibull | 2 |
| Tübingen | 2 |
| Tönges | 2 |
| Tumor | 2 |
| Stoyanov | 2 |
| Swine | 2 |
| SwIV | 2 |
| Suzuki | 2 |
| Surg | 2 |
| Superiore | 2 |
| Super | 2 |
| Summer | 2 |
| Sudden | 2 |
| Subset | 2 |
| Studio | 2 |
| Structured | 2 |
| Structural | 2 |
| Stroke | 2 |
| Strategies | 2 |
| Stimulator | 2 |
| Syndrome- | 2 |
| Steyerberg | 2 |
| Steroid | 2 |
| Stephen | 2 |
| Stents | 2 |
| Stendal | 2 |
| Stefan | 2 |
| Steering | 2 |
| Statistics | 2 |
| Standing | 2 |
| Stan | 2 |
| Stage | 2 |
| Staff | 2 |
| Stability | 2 |
| Spring | 2 |
| Switch | 2 |
| T12 | 2 |
| Trust | 2 |
| Tetsuro | 2 |
| Treatments | 2 |
| Training | 2 |
| Tracheal | 2 |
| Toussie | 2 |
| Toll | 2 |
| Tolerance | 2 |
| Tobias | 2 |
| Tibialis | 2 |
| Third | 2 |
| Thermo | 2 |
| Therapeutic | 2 |
| Th2-type | 2 |
| Text | 2 |
| Teva | 2 |
| Test | 2 |
| T2 | 2 |
| Teresa | 2 |
| Telemed | 2 |
| Teledentistry | 2 |
| Tc | 2 |
| Tang | 2 |
| Tan | 2 |
| Takeshi | 2 |
| TRL | 2 |
| TLR4 | 2 |
| TLR3 | 2 |
| TEVA | 2 |
| TAC | 2 |
| TA | 2 |
| T2DM | 2 |
| arbidol | 2 |
| association | 2 |
| Specific | 2 |
| renin | 2 |
| oseltamivir | 2 |
| paranasal | 2 |
| peptidase-4 | 2 |
| polyhydramnios | 2 |
| pyrin | 2 |
| rehabilitation | 2 |
| resp | 2 |
| b. | 2 |
| resveratrol | 2 |
| reticularis | 2 |
| retiform | 2 |
| sciences | 2 |
| secretome | 2 |
| selectin | 2 |
| orifice | 2 |
| orf7b | 2 |
| orf7a | 2 |
| orf6 | 2 |
| orf10 | 2 |
| orange | 2 |
| nucleoprotein | 2 |
| nsp9 | 2 |
| nsp15 | 2 |
| nsp13 | 2 |
| nsp12 | 2 |
| nsp1-nsp16 | 2 |
| nsp1-nsp11 | 2 |
| nonrespiratory | 2 |
| non | 2 |
| neutrophilia | 2 |
| myohemoglobin | 2 |
| selisistat | 2 |
| sistemática | 2 |
| spike(RBD)-ACE2 | 2 |
| γCoV | 2 |
| g | 2 |
| Modeling | 2 |
| ≥70 | 2 |
| ≥2 | 2 |
| ≥14 | 2 |
| −90 | 2 |
| −80 | 2 |
| −71 | 2 |
| −23 | 2 |
| −2.5 | 2 |
| ∆G | 2 |
| λ | 2 |
| δCoVs | 2 |
| δCoV | 2 |
| βCoVs | 2 |
| spinosad | 2 |
| µg | 2 |
| y.o.a | 2 |
| versión | 2 |
| vasculopathy | 2 |
| vasculitis | 2 |
| urology | 2 |
| urgencias | 2 |
| tp/(tp | 2 |
| thalamus | 2 |
| th | 2 |
| teleorthodontics | 2 |
| tagged | 2 |
| síndrome | 2 |
| sustentacular | 2 |
| multiorgan | 2 |
| monogenic | 2 |
| mmol | 2 |
| dL | 2 |
| gamma | 2 |
| fp | 2 |
| favipiravir | 2 |
| express | 2 |
| ex | 2 |
| etomidate | 2 |
| eosin | 2 |
| enfermería | 2 |
| endoscopy | 2 |
| endoscopic | 2 |
| electro | 2 |
| east | 2 |
| della | 2 |
| deacetylates | 2 |
| dG | 2 |
| glycocalyx | 2 |
| cytopenia | 2 |
| coryza | 2 |
| corona | 2 |
| colonoscopy | 2 |
| cobicistat | 2 |
| choroidal | 2 |
| chemiluminescentmicroparticle | 2 |
| cause(s | 2 |
| caspase-3 | 2 |
| cTn | 2 |
| brodalumab | 2 |
| bradykinesia | 2 |
| bell | 2 |
| belatacept | 2 |
| general | 2 |
| h. | 2 |
| mitogens | 2 |
| ketamine | 2 |
| microRNAs | 2 |
| miR-19a | 2 |
| meningism | 2 |
| mayo | 2 |
| mas | 2 |
| male | 2 |
| mTc | 2 |
| mRNAs | 2 |
| mL. | 2 |
| mHealth | 2 |
| lumbosacral | 2 |
| log | 2 |
| kinase-3 | 2 |
| kettle | 2 |
| keratinocyte | 2 |
| hepatopathy | 2 |
| kalign | 2 |
| kB | 2 |
| k. | 2 |
| juvantibus | 2 |
| italiana | 2 |
| intermolar | 2 |
| inhibitor-1 | 2 |
| infarct | 2 |
| immunoassays | 2 |
| i.e | 2 |
| hypertriglyceridemia | 2 |
| hyperplasia | 2 |
| human | 2 |
| heptad | 2 |
| Sports | 2 |
| von | 2 |
| Species | 2 |
| Peer | 2 |